AU2001233529A1 - Probiotic therapy for newborns - Google Patents
Probiotic therapy for newbornsInfo
- Publication number
- AU2001233529A1 AU2001233529A1 AU2001233529A AU3352901A AU2001233529A1 AU 2001233529 A1 AU2001233529 A1 AU 2001233529A1 AU 2001233529 A AU2001233529 A AU 2001233529A AU 3352901 A AU3352901 A AU 3352901A AU 2001233529 A1 AU2001233529 A1 AU 2001233529A1
- Authority
- AU
- Australia
- Prior art keywords
- newborns
- probiotic therapy
- probiotic
- therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18170200P | 2000-02-10 | 2000-02-10 | |
US60181702 | 2000-02-10 | ||
PCT/CA2001/000157 WO2001058465A2 (en) | 2000-02-10 | 2001-02-09 | Probiotic therapy for newborns |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001233529A1 true AU2001233529A1 (en) | 2001-08-20 |
Family
ID=22665417
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001233529A Abandoned AU2001233529A1 (en) | 2000-02-10 | 2001-02-09 | Probiotic therapy for newborns |
Country Status (3)
Country | Link |
---|---|
US (1) | US6613549B2 (en) |
AU (1) | AU2001233529A1 (en) |
WO (1) | WO2001058465A2 (en) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ137699A0 (en) * | 1999-07-02 | 1999-07-22 | University Of New England, The | Control of acidosis |
US20020044926A1 (en) * | 1999-12-10 | 2002-04-18 | Gregor Reid | Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
US20040062757A1 (en) * | 2001-06-05 | 2004-04-01 | Finegold Sydney M. | Method of testing gastrointestinal diseases associated with species of genus clostridium |
US7214370B2 (en) | 2000-12-18 | 2007-05-08 | Probiohealth, Llc | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
EP1264893A1 (en) | 2001-06-08 | 2002-12-11 | Teagasc Dairy Products Research Centre | CLA biosynthesis by bifidobacteria |
GB0212975D0 (en) | 2002-06-06 | 2002-07-17 | Mars Uk Ltd | Mammalian animal composition |
CA2549115C (en) * | 2002-09-26 | 2013-07-16 | Vita-Herb Nutriceuticals, Inc. | Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
AU2004241895B2 (en) * | 2003-05-22 | 2008-05-01 | Synbiotics Ab | A probiotic composition comprising at least two lactic acid bacterial strains which are able to colonise the gastrointestinal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and a fiber fermenting property |
GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
ITMI20032391A1 (en) * | 2003-12-05 | 2005-06-06 | Consiglio Nazionale Ricerche | MENSA OLIVES CONTAINING PROBIOTIC MICRO-ORGANISMS. |
RU2006136927A (en) * | 2004-03-19 | 2008-04-27 | Даниско А/С (Dk) | SHORTENING EMULSOR COMPOSITION |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
US20060233762A1 (en) * | 2005-04-15 | 2006-10-19 | Mcmahon Robert J | Method for treating or preventing systemic inflammation in formula-fed infants |
US7303745B2 (en) * | 2005-04-15 | 2007-12-04 | Bristol-Myers Squibb Company | Method for preventing or treating the development of respiratory allergies |
TWI362949B (en) * | 2005-09-13 | 2012-05-01 | Bion Tech Inc | Intestines dissolving nature is able to bear the hydrochloric acid in gastric juice and wrap up the benefit covered and grow the fungus of makes up |
EP1776877A1 (en) * | 2005-10-21 | 2007-04-25 | N.V. Nutricia | Method for stimulating the intestinal flora |
US20080107699A1 (en) * | 2006-10-25 | 2008-05-08 | Mark Spigelman | Method of using topical probiotics for the inhibition of surface contamination by a pathogenic microorganism and composition therefor |
EP1952703B1 (en) | 2007-02-02 | 2010-08-25 | May, Amadeus Alexander | Product including living probiotic micro organisms |
EP2114423B2 (en) * | 2007-02-28 | 2020-01-01 | MJN U.S. Holdings LLC | Inactivated lactobacillus rhammosus gg for treating systemic inflammation in infants |
WO2008119012A2 (en) * | 2007-03-27 | 2008-10-02 | The Procter & Gamble Company | Methods and kits for administering probiotics |
ES2600481T3 (en) * | 2007-10-11 | 2017-02-09 | Promovita Ingredients Limited | Preparation for treating an intestinal infection comprising oligosaccharides and insoluble cellular material |
EP2668854B1 (en) | 2008-03-28 | 2015-07-01 | Nestec S.A. | Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings |
WO2010002241A1 (en) * | 2008-06-30 | 2010-01-07 | N.V. Nutricia | Nutritional composition for infants delivered via caesarean section |
US20110223137A1 (en) * | 2008-12-05 | 2011-09-15 | Nestec S.A. | Compositions for use in low-birth weight infants |
WO2011044516A2 (en) * | 2009-10-09 | 2011-04-14 | Prothera, Inc. | Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in a person diagnosed with an autism spectrum disease |
FI20096402A0 (en) * | 2009-12-28 | 2009-12-28 | Suomen Punainen Risti Veripalv | Use of blood group status II |
FI20096400A0 (en) * | 2009-12-28 | 2009-12-28 | Suomen Punainen Risti Veripalv | Use of blood group status I |
US9707207B2 (en) | 2010-05-26 | 2017-07-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for diagnosing, preventing, and treating neurological diseases |
EP2394920A1 (en) * | 2010-06-14 | 2011-12-14 | Nestec S.A. | Dispensing container for probiotics |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
CN110917220A (en) | 2013-02-04 | 2020-03-27 | 赛里斯治疗公司 | Therapeutic compositions and methods of use thereof |
EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
AU2014232370B2 (en) | 2013-03-15 | 2018-11-01 | Seres Therapeutics, Inc. | Network-based microbial compositions and methods |
RU2722482C2 (en) | 2013-11-25 | 2020-06-01 | Серес Терапеутикс, Инк. | Synergistic bacterial compositions and methods for preparing and using them |
US9956282B2 (en) | 2013-12-16 | 2018-05-01 | Seres Therapeutics, Inc. | Bacterial compositions and methods of use thereof for treatment of immune system disorders |
WO2016168729A1 (en) * | 2015-04-17 | 2016-10-20 | Evolve Biosystems Inc. | Delivering non-pathogenic, intestinally beneficial bacteria to a patient having a feeding tube |
CN111212655A (en) | 2017-08-14 | 2020-05-29 | 赛里斯治疗公司 | Compositions and methods for treating cholestatic diseases |
TWI718402B (en) * | 2018-08-16 | 2021-02-11 | 葡萄王生技股份有限公司 | An active substance of lactobacillus paracasei gks6, a composition comprising thereof and its use for promoting longevity |
US11524098B2 (en) * | 2018-09-14 | 2022-12-13 | Avent, Inc. | Systems and methods for biofilm inoculation |
EP4032536A1 (en) | 2021-01-26 | 2022-07-27 | Probisearch, S.L.U. | Probiotic composition for infants and its uses |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3984575A (en) * | 1974-02-06 | 1976-10-05 | Microlife Technics, Inc. | Bacterial compositions for changing the digestive system bacteria in animals |
SU1743607A1 (en) * | 1990-02-05 | 1992-06-30 | 2-й Московский государственный медицинский институт им.Н.И.Пирогова | Method for prevention of intestinal dysbacteriosis in newborn infants |
WO1995033046A1 (en) * | 1994-05-26 | 1995-12-07 | Bracco S.P.A. | Lactobacillus strains of human origin, their compositions and uses thereof |
US5902578A (en) | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
US6132710A (en) * | 1997-03-17 | 2000-10-17 | Probiotix, Inc. | Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof |
US5902743A (en) | 1998-03-20 | 1999-05-11 | Wisconsin Alumni Research Foundation | Probiotic bifidobacterium strain |
CA2374937A1 (en) * | 1999-05-25 | 2000-11-30 | Gregor Reid | Oral administration of lactobacillus for the maintenance of health in women |
-
2001
- 2001-02-09 US US09/780,841 patent/US6613549B2/en not_active Expired - Lifetime
- 2001-02-09 AU AU2001233529A patent/AU2001233529A1/en not_active Abandoned
- 2001-02-09 WO PCT/CA2001/000157 patent/WO2001058465A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US20010036453A1 (en) | 2001-11-01 |
US6613549B2 (en) | 2003-09-02 |
WO2001058465A3 (en) | 2002-04-25 |
WO2001058465A2 (en) | 2001-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001233529A1 (en) | Probiotic therapy for newborns | |
AUPQ899700A0 (en) | Probiotic recolonisation therapy | |
AU2001252135A1 (en) | Therapeutic agents | |
WO2002005740A8 (en) | Pulmonary therapy apparatus | |
AU2001234846A1 (en) | Integrated resuscitation | |
AU2001245792A1 (en) | Proning bed | |
GB0028429D0 (en) | Therapy | |
AU2002219229A1 (en) | Means for the diagnosis and therapy of CTCL | |
AU7882900A (en) | Hydrotherapy bed | |
AU2001238488A1 (en) | Human kinases | |
AU2002332074A1 (en) | Padded absorbent article | |
AU2001234178A1 (en) | Modified bdnf | |
AU2002227925A1 (en) | Human beta-defensin-3 | |
AU2001270129A1 (en) | Human phosphodiesterases | |
AU2002335667A1 (en) | Modified reoviral therapy | |
AU2001273903A1 (en) | Therapeutic agents | |
AU2001286341A1 (en) | Therapeutic bio-energy unit | |
AU2001255573A1 (en) | Human kinases | |
AU2001275696A1 (en) | Therapeutic agent | |
AU2001292897A1 (en) | Novel therapy | |
WO2001085090A8 (en) | Therapy device | |
AU2001260789A1 (en) | Wheelchair | |
AU3447900A (en) | Assay for therapy | |
AU4060401A (en) | Massaging armchairs | |
AU2001252445A1 (en) | Sanitary bed |